Key result
Levosimendan demonstrated superiority over dobutamine for the treatment of right ventricle failure.
Why the study?
Does levosimendan improve outcomes compared to dobutamine in right ventricle failure?
Does levosimendan improve outcomes compared to dobutamine in right ventricle failure?
Answers are grounded in this paper and cite their sources.
The title suggests levosimendan is superior to dobutamine in right ventricle failure, but no data is provided in the abstract.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ruß et al. (2009) studied this question. Levosimendan demonstrated superiority over dobutamine for the treatment of right ventricle failure.
Synapse has enriched 10 related papers. Consider them for comparative context: